91 related articles for article (PubMed ID: 2256262)
21. Colorectal carcinoma: is screening possible?
Bonelli L
Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for advanced colorectal adenomas: a pooled analysis.
Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
[TBL] [Abstract][Full Text] [Related]
23. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors.
Piñol V; Andreu M; Castells A; Payá A; Bessa X; Jover R;
Dis Colon Rectum; 2004 Jul; 47(7):1192-200. PubMed ID: 15164252
[TBL] [Abstract][Full Text] [Related]
24. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma.
Keller R; Winde G; Terpe HJ; Foerster EC; Domschke W
Endoscopy; 2002 Oct; 34(10):801-7. PubMed ID: 12244502
[TBL] [Abstract][Full Text] [Related]
26. [The role of and suitability of the occult fecal blood test in a preventive program for colorectal carcinoma].
Ebling Z; Hadzić N
Lijec Vjesn; 1989 Dec; 111(12):432-6. PubMed ID: 2636303
[TBL] [Abstract][Full Text] [Related]
27. [Costs and benefits of screening for colorectal tumors using the Hemoccult test in asymptomatic individuals 45-60 years of age].
Fric P; Zoubek V; Dvoráková H; Roth Z
Cas Lek Cesk; 1991 Mar; 130(12):370-3. PubMed ID: 1903329
[TBL] [Abstract][Full Text] [Related]
28. Argon plasma coagulation after piecemeal polypectomy of sessile colorectal adenomas: long-term follow-up study.
Regula J; Wronska E; Polkowski M; Nasierowska-Guttmejer A; Pachlewski J; Rupinski M; Butruk E
Endoscopy; 2003 Mar; 35(3):212-8. PubMed ID: 12584639
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp.
Nakama H; Fukazawa K
Hepatogastroenterology; 2002; 49(43):157-9. PubMed ID: 11941942
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
[TBL] [Abstract][Full Text] [Related]
31. [Screening tests for colon cancer - a new comparison Haemoccult - hemoFEC and review of 9 years clinical experience with Haemoccult (author's transl)].
Gnauck R
Z Gastroenterol; 1982 Feb; 20(2):84-92. PubMed ID: 6977955
[TBL] [Abstract][Full Text] [Related]
32. [The effect of immunofecal occult blood test on colorectal cancer screening].
Yang HY; Ge ZZ; Dai J; Li XB; Gao YJ
Zhonghua Nei Ke Za Zhi; 2008 Aug; 47(8):642-5. PubMed ID: 19080296
[TBL] [Abstract][Full Text] [Related]
33. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.
Huang EH; Whelan RL; Gleason NR; Maeda JS; Terry MB; Lee SW; Neugut AI; Forde KA
Surg Endosc; 2001 Jul; 15(7):646-8. PubMed ID: 11591960
[TBL] [Abstract][Full Text] [Related]
34. Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience.
Matarese VG; Feo CV; Pezzoli A; Trevisani L; Brancaleoni M; Gullini S
Eur J Cancer Prev; 2007 Aug; 16(4):292-7. PubMed ID: 17554201
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
36. Subjects older than 60 years with negative findings on sigmoidoscopy should still undergo colonoscopy.
Yoshinaga M; Watabe R; Takeda H; Yanagisawa J; Higuchi K; Tsuda Y; Harada N; Nawata H; Ikeda K
Hepatogastroenterology; 2002; 49(45):668-71. PubMed ID: 12063966
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
[TBL] [Abstract][Full Text] [Related]
38. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
39. Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial.
Little J; Owen RW; Fernandez F; Hawtin PG; Hill MJ; Logan RF; Thompson MH; Hardcastle JD
Dis Colon Rectum; 2002 Sep; 45(9):1233-41. PubMed ID: 12352242
[TBL] [Abstract][Full Text] [Related]
40. [Clinical analysis of 168 cases of multiple primary colorectal carcinoma].
Cai H; Dong RZ; Wu JH; Zhu HY; Wang YN; Shi YQ; Mo SJ
Zhonghua Wai Ke Za Zhi; 2008 Mar; 46(5):370-4. PubMed ID: 18785535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
